Navigation Links
Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
Date:10/10/2010

the combination was 57 percent compared with the 30 percent reported for pemetrexed alone. Progression-free survival more than doubled when TTF Therapy was added to pemetrexed, to 22-28 weeks versus the 12 weeks previously reported for pemetrexed alone1. The only reported adverse event for TTF Therapy was mild to moderate skin irritation at the treatment site.

"These NSCLC data further validate TTF Therapy as a viable approach to treating deadly cancers," said Asaf Danziger, chief executive officer of Novocure. "We have seen positive clinical success in both phase II and phase III studies, alone and in combination with chemotherapy, and believe TTF Therapy has the potential to be effective in a range of solid tumors."

TTF Therapy slows and reverses tumor cell proliferation by inhibiting mitosis, the process by which cells divide and replicate themselves. The NovoTTF-100L device, which weighs about six pounds (three kilograms), creates a low-intensity, alternating electric field within the tumor that exerts physical forces on electrically charged cellular components, preventing the normal mitotic process and causing cancer cell death prior to division.

Novocures NovoTTF-100A device has received its CE Mark and is approved for sale in six European countries as a treatment for glioblastoma brain tumors. The NovoTTF-100L device has received its CE Mark as a treatment for NSCLC and will be launched in Europe in the near future. Novocure is also planning to file an investigational device application with the FDA for a phase III study of TTF Therapy in early stage NSCLC in the near future.


'/>"/>

Contact: Anne McPherson
anne.mcpherson@edelman.com
415-486-3273
Edelman Public Relations
Source:Eurekalert

Page: 1 2

Related biology news :

1. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
2. GEN reports on the greening of the life sciences
3. Aware, Inc. Reports Second Quarter 2010 Financial Results
4. GEN reports on rediscovered technology to bolster proteomics research
5. BIO-key® Reports Strong 2010 Second Quarter and Six Month Financial Results
6. International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit
7. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
8. New climate change reports underscore need for action
9. BIO-key(R) Reports First Quarter 2010 Financial Results
10. Survey reports latest honey bee losses
11. Grupo Radio Centro Reports First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... Nov. 17, 2014 The Parenteral Drug Association (PDA) ... agencies will speak and at least seven more will participate ... the Omni Shoreham Hotel in Washington D.C. ... to have significant support from the regulatory agencies in ... in our effort to help advance the use ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... improving bone health in postmenopausal women and people of ... found a simple, proactive solution to help prevent fractures and ... tested numerous fruits, including figs, dates, strawberries and raisins, and ... on bone density that dried plums, or prunes, have," said ...
... -- Researchers at the University of California, Riverside along ... grant from the Department of Energy to study and ... can cut harmful emissions and reduce fuel use by ... to develop and demonstrate a comprehensive driver feedback technology ...
... turmeric and long-term use of garlic all herbal ... may negatively impact chemotherapy treatment according to a ... Oncology (ASCO) meeting in Chicago this summer. Researchers ... that these popular supplements may intensify or weaken the ...
Cached Biology News:No bones about it: Eating dried plums helps prevent fractures and osteoporosis 2Study aims to improve fuel economy by 30 percent 2Study aims to improve fuel economy by 30 percent 3Popular herbal supplements may adversely affect chemotherapy treatment 2Popular herbal supplements may adversely affect chemotherapy treatment 3
(Date:12/13/2014)... The DNA Microarray market market was valued ... to grow at a CAGR of 15.2% from ... of the DNA Microarray for an in-depth analysis ... of various tables and figures. , http://www.micromarketmonitor.com/market-report/dna-microarray-reports-5177428198.html ... of instrument, consumables, and services, where the consumables ...
(Date:12/13/2014)... 13, 2014 The “Global Synthetic ... market drivers, threats, opportunities, and challenges. , The ... major players, namely, Thermo Fisher Scientific, Inc. (U.S.), ... players jointly accounted for approximately ~65% of the ... Full Copy for This Report @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html ...
(Date:12/13/2014)... 13, 2014 QuickSTAT is making significant ... Cold Chain capabilities, and is delighted to announce the ... to serve Life Science clients in the region. , ... controlled-ambient warehouse, will provide 24/7 transportation and logistics services, ... drugs, patient-clinical specimens, API, following IATA rules and EU ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and Markets ... addition of the "Glucose Sensors: the Next ... http://photos.prnewswire.com/prnh/20130307/600769 The ... designs is giving hope for a better future ... monitors that can measure glucose levels accurately and ...
Breaking Biology Technology:DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Glucose Sensors: the Next Generation 2Glucose Sensors: the Next Generation 3
... 15 Cytopia Limited (ASX: CYT) announced that it ... (VDA) CYT997 at the forthcoming 100th Annual Meeting of ... USA. Dr David Segal, Principal Scientist at Cytopia, will ... Experimental and Molecular Therapeutics 2 poster session on ...
... -- China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company producing over-the-counter,drugs in the People,s ... a conference call at 10:00 a.m. Eastern Daylight Time ... quarter and fiscal year 2008,financial results. , ...
... NATICK, Mass., April 15 Boston Scientific (NYSE: ... reduce its GAAP earnings for the first quarter. ... results on April 20.As the Company disclosed last month, ... the District Court,s decision that Johnson & Johnson,s (J&J) ...
Cached Biology Technology:Cytopia Presentation on VDA CYT997 at AACR Conference 2China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results 2Boston Scientific Announces First Quarter Special Items 2Boston Scientific Announces First Quarter Special Items 3Boston Scientific Announces First Quarter Special Items 4Boston Scientific Announces First Quarter Special Items 5
... biomarker discovery projects require screening through ... distinguish clinically relevant data from normal ... Manager is now available to help ... and data flood inherent to biomarker ...
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
... provider of X-ray crystallography services for ... services to its pharmaceutical and biotechnology ... of drug-like fragments to the active ... allowing scientists to develop novel, high-affinity ...
Biology Products: